Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE)
- Drake, M.J.
- Chapple, C.
- Esen, A.A.
- Athanasiou, S.
- Cambronero, J.
- Mitcheson, D.
- Herschorn, S.
- Saleem, T.
- Huang, M.
- Siddiqui, E.
- Stölzel, M.
- Herholdt, C.
- MacDiarmid, S.
ISSN: 1873-7560, 0302-2838
Argitalpen urtea: 2016
Alea: 70
Zenbakia: 1
Orrialdeak: 136-145
Mota: Artikulua